DOSSIER · UPDATED 18 NOV 2025

Exsilio Therapeutics

Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such…

exsiliotx.com ↗Claim this profile

Founded: 2022
Headcount: 14
Open roles: 0
Last raised: Series A · $82M

SECTION I · THE BRIEF

Inside Exsilio Therapeutics

Brief #14617Updated 18 NOV 2025BOSTONMEDICAL ORGANIZATIONSSERIES A

Employbl Dossier

Exsilio Therapeutics

Founded: 2022
Headcount: 14
Open roles: 0
Last raised: Series A · $82M

Section II — RestrictedMembers only

Tech stack (Exsilio Therapeutics engineering primaries)
Hiring focus this quarter
Interview format & rubric
Comp bands by level
Decision-makers in talent
Recent news & moves

Open Exsilio Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

Categorized in

Company Collections

These are collections Exsilio Therapeutics is a part of. Click on the collection name to view similar companies.